Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary

Human Reproduction

Volumn 12, Issue 11, 1997, Pages 2483-2488

  Gosden, R G ^a,f   Wade, J C ^b   Fraser, H M ^c   Sandow, J ^d   Faddy, M J ^e  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d SANOFI   (France)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Follicle; Gonadotrophin releasing hormone; Mouse; Ovary; Radiation

Indexed keywords

GONADORELIN ANTAGONIST; GONADOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HYPOGONADOTROPIC HYPOGONADISM; MOUSE; NONHUMAN; OVARY; OVARY FOLLICLE; RADIATION DOSE; RADIATION STERILIZATION; RADIOSENSITIVITY; X RAY;

EID: 0030730644     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.11.2483     Document Type: Article

References (38)

1. Apperley, J.F. and Reddy, N. (1995) Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev., 9, 93-116.
2. Ataya, K.M., Weintraub, A., McKanna, J. et al. (1985) A luteinizing hormone releasing hormone agonist for the prevention of chemotherapy induced ovarian follicular loss in rats. Cancer Res., 45, 3651-3656.
3. 3H-thymidine uptake by LHRH agonists: a mechanism of preventing damage by cytotoxic agents. Cancer Res., 48, 7252-7256.
4. Ataya, K., Pydyn, E., Ramahi-Ataya, A. et al. (1995a) Is radiation-induced ovarian failure in rhesus monkeys preventable by luteinizing hormone releasing hormone agonists?: preliminary observations. J. Clin. Endocrinol. Metab., 80, 790-795.
5. Ataya, K., Rao, L.V., Lawrence, E. et al. (1995b) Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol. Reprod., 52, 365-372.
6. Atkinson, H.G., Apperley, J.F., Dawson, K. et al. (1994) Successful pregnancy after embryo cryopreservation after BMT for CML. Lancet, 344, 199.
7. Baker, T.G. (1971) Radiosensitivity of mammalian oocytes with particular reference to the human female. Am. J. Obstet. Gynecol., 110, 746-761.
8. Beaumont, H.M. (1969) Effect of hormonal environment on the radiosensitivity of oocytes. In Radiation Biology of the Fetal and Juvenile Mammal. Proceedings of the 9th Annual Conference, Washington, DC, USA. pp. 943-953.
9. Blumenfeld, Z., Avivi, I., Linn, S. et al. (1996) Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum. Reprod., 11, 1620-1626.
10. 6-luteinizing hormone releasing hormone microcapsules against cyclophosphamide induced gonadotoxicity in female rats. Br. J. Cancer, 61, 861-865.
11. Brown, J.R., Modell, E., Obasaju, M. et al. (1996) Natural cycle in-vitro fertilization with embryo cryopreservation prior to chemotherapy for carcinoma of the breast. Hum. Reprod., 11, 197-199.
12. Cattanach, B.M., Iddon, C.A., Charlton, H.M. et al. (1977) Gonadotrophin hormone-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature, 269, 338-340.
13. Chapman, R.M. and Sutcliffe, S.B. (1981) Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood, 58, 849-851.
14. Chatterjee, R. and Goldstone, A.H. (1996) Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant., 17, 5-11.
15. Faddy, M.J., Telfer, E. and Gosden, R.G. (1987) The kinetics of preantral follicle development in ovaries of CBA/Ca mice during the first 14 weeks of life. Cell Tissue Kinet., 20, 551-560.
16. Faddy, M.J., Gosden, R.G., Gougeon, A. et al. (1992) Accelerated disappearance of ovarian follicles in mid-life - implications for forecasting menopause. Hum. Reprod., 7, 1342-1346.
17. Familiari, G., Caggiati, A., Nottola, S.A. et al. (1993) Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum. Reprod., 8, 2080-2087.
18. Gosden, R.G. (1990a) Restitution of fertility in sterilized mice by transferring primordial ovarian follicles. Hum. Reprod., 5, 499-504.
19. Gosden, R.G. (1990b) Control of recruitment of preantral follicles in mammalian ovaries. In Dale, B. (ed.), Mechanism of Fertilization: Plants to Animals. Springer-Verlag, Berlin, Germany, NATO ASI Series, Vol. H45, pp. 101-113.
20. Gosden, R.G. and Aubard, Y. (1996) Ovarian and Testicular Tissue Transplantation. Medical Intelligence Unit, R.G.Landes Co., Austin, YX, USA.
21. Gosden, R.G., Rutherford, A.J, and Norfolk, D. (1997) Transmission of malignant cells in ovarian grafts. Hum. Reprod., 12, 403.
22. Gougeon, A. (1996) Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr. Rev., 17, 121-155.
23. Gougeon, A., Ecochard, R. and Thalabard, J.C. (1994) Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol. Reprod., 50, 653-663.
24. Halpin, D.M.G., Charlton, H.M. and Faddy, M.J. (1986) Effects of gonadotrophin deficiency on follicular development in hypogonadal (hpg) mice. J. Reprod. Fertil., 78, 119-125.
25. Horning, S.J., Hoppe, R.T., Kaplan, H.S. et al. (1981) Female reproductive potential after treatment for Hodgkin's disease. N. Engl. J. Med., 304, 1377-1382.
26. 10] luteinizing hormone-releasing hormone ethylamide on developing rat ovarian follicles. Cancer Res., 47, 5005-5008.
27. 10]-LHRH does not protect the fecundity of rats exposed to high dose unilateral ovarian irradiation. Reprod. Toxicol., 5, 385-388.
28. König, W., Kolar, C., Sandow, J. et al. (1989) Glycosylated gonadoliberin antagonists. In Jung, G. and Bayer, E. (eds), Peptides 1988. De Gruyter, Berlin, Germany, pp. 334-335.
29. Kreuser, E.-D., Klingmüller, D. and Thiel, E. (1993) The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation. Eur. Urol., 23, 157-164.
30. Laing, S.C., Gosden, R.G. and Fraser, H.M. (1984) Cytogenetic analysis of mouse oocytes after experimental induction of follicular overripening. J. Reprod. Fertil. 70, 387-393.
31. Marmor, D. (1995) Fonction gonadique et reproduction après traitements antimitotiques ou immunosuppresseurs. Ref. Gynecol. Obstet., 3, 348-355.
32. Mathur, S., Nandchahal, K. and Bhartiya, H. (1991) Radioprotection by MPG of mice ovaries exposed to sublethal gamma radiation doses at different postnatal ages. Acta Oncol., 30, 981-983.
33. Newton, H., Aubard, Y., Rutherford, A. et al. (1996) Low temperature storage and grafting of human ovarian tissue. Hum. Reprod., 11, 1487-1491.
34. Oktay, K., Newton, H., Aubard, Y. et al. (1998) Cryopreservation of immature human oocytes and ovarian tissue - an emerging technology? Fertil. Steril., in press.
35. Peters, H. (1969) The effect of radiation in early life on the morphology and reproductive function of the mouse ovary. In McLaren, A. (ed.), Advances in Reproductive Physiology. Logos Press, London, UK. Vol. 4, pp. 149-185.
36. Sanders, J.E., Hawley, J., Levy, W. et al. (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulphan or total-body irradiation and bone marrow transplantation. Blood, 87, 3045-3052.
37. Stoeckemann, K. and Sandow, J. (1993) Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (Hoe 013) and the LHRH agonist buserelin on dimethylbenz[a]anthracene-induced mammary carcinoma: studies with slow-release formulations. J. Cancer Res. Clin. Oncol., 119, 457-162.
38. Wallace, W.H.B., Shalet, S.M., Hendry, J.H. et al. (1989) Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br. J. Radiol., 62, 995-998.